BCL2 and Alzheimer disease: Du and colleagues [158] investigated neurotrophin signaling changes in rat models of Alzheimer’s disease, specifically through the intrahippocampal administration of Aβ25–35, and revealed pro-apoptotic effects including increased Bax and caspase-3 and decreased Bcl-2 expression.